Features of drug pharmacotherapy in patients with heart failure after pacemaker implantation

Author:

Voronenko O.S.1ORCID

Affiliation:

1. V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Abstract

Over the past decades, an increase in mortality from chronic heart failure (CHF) has been recorded, for the treatment of which the implantation of an electrocardiostimulator can be used. The medical support of the patient with a pacemaker was optimized depending on the functional class (FC) of CHF. An increase in both the frequency of prescription and the dose of (3-adrenergic receptor blockers with an increase in the FC of CHF in patients with CHF at a one-year follow-up period after implantation of pacemakers was shown. This not only improves myocardial contractility, but also reduces the risk of complications of pacing. Patients with implanted pacemakers require careful titration of medications taking into account the FC of CHF, especially with regard to its high FC, primarily for therapy with angiotensin-converting enzyme inhibitors, antiplatelet agents, and antiarrhythmic drugs. Keywords: chronic heart failure, pacemaker implantation, drug therapy.

Publisher

Kharkiv National Medical University

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference12 articles.

1. Derzhavna sluzhba statystyky Ukrainy. (2020). Naselennia Ukrainy za 2019 rik. Demohrafichnyi shchorichnyk [Population of Ukraine 2019. Demographic Yearbook]. M. Timonina (Responsible for the release). Kyiv, 181 p. Retrieved from http://www.ukrstat.gov.ua/druk/publicat/kat_u/2020/zb/10/zb_nas_2019.pdf [in Ukrainian].

2. Ehorov, D.F., & Hordeiev, O.L. (2005). Diahnostika і lecheniie patsiientov s implantirovannymi antiaritmicheskimi ustroistvami [Diagnostics and treatment of patients with implanted antiarrhythmic devices]. St. Petersburg: Chelovek, 256 p. [in Russian].

3. Iqbal, J., Francis, L., & Reid, J. (2010). Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality. European Journal Heart Failure, vol. 12, issue 9, pp. 1002–1008. DOI: 10.1093/eurjhf/hfqll4. PMID: 20615920.

4. Gould, P.A., & Kaye, D.M. (2002). Clinical treatment regimens for chronic heart failure: a review. Expert Opin. Pharmacother., vol. 3, issue 11, pp. 1569–1576. DOI: 10.1517/14656566.3.11.1569. PMID: 12437491.

5. Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., … & Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 28(1), 1–39.e14. DOI: 10.1016/j.echo.2014.10.003. PMID: 25559473.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3